Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

27,695 signal articles · 237 in last 24h · 134,221 total before filter · latest 49m ago
237last 24h
1113last 7d
181● bullish (7d)
133● bearish (7d)
209publishers
AllMacro294Earnings372M&A76Regulatory27Product11Analyst15
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
U.S. Stocks Down as Oil Rises Ahead of Inflation Data
The Wall Street Journal23d agoneutral
U.S. Stocks Down as Oil Rises Ahead of Inflation Data

U.S. stocks slid as negotiations about the future of the Strait of Hormuz remain deadlocked, pushing oil prices up ahead of key inflation data Wednesday. Oil futures rose $1.07, or 1.3%, to $83.20 a barrel, amid signs that the Middle East conflict may escalate again. The yield on the 10-year Treasury note declined 0.014 percentage point to 4.683%.

AbbVie (ABBV) Gains On Botox Filing, Is The 9% Discount Still There?
Simply Wall St.23d agoneutral
AbbVie (ABBV) Gains On Botox Filing, Is The 9% Discount Still There?

AbbVie (ABBV) is back in focus after Allergan Aesthetics reported that the FDA accepted a supplemental Biologics License Application for Botox Cosmetic targeting masseter muscle prominence in adults, which would be a potential fifth U.S. aesthetic indication. See our latest analysis for AbbVie. Alongside Allergan Aesthetics' Botox update and several recent approvals and guidance changes, AbbVie’s share price has moved to $247.97, with a 90 day share price return of 19.3% and a 1 year total...

AbCellera Biologics (ABCL) Could Be 33% Overvalued Following ABCL635 Phase 2 Results
Simply Wall St.23d agoneutral
AbCellera Biologics (ABCL) Could Be 33% Overvalued Following ABCL635 Phase 2 Results

Why ABCL635’s Phase 2 data matters for AbCellera Biologics stock AbCellera Biologics (ABCL) has become a focus for many biotech investors after announcing that ABCL635 met primary endpoints in a Phase 2 trial for menopause related hot flashes. The single dose of ABCL635 produced statistically significant reductions in both the frequency and severity of vasomotor symptoms versus placebo and was reported as well tolerated, with additional benefits in sleep and patients’ overall perception of...

Moody's (MCO) Faces Private Credit Risk, Is The Stock Already Fully Valued?
Simply Wall St.23d agoneutral
Moody's (MCO) Faces Private Credit Risk, Is The Stock Already Fully Valued?

Mounting risks in private credit, especially weaker recoveries on software loans flagged by SLR Capital Partners, have pushed investors to reassess how Moody's (MCO) is exposed to credit conditions and changing expectations around default outcomes. See our latest analysis for Moody's. Moody's share price is US$478.14, with a 90 day share price return of 5.84% but a year to date share price return that is down 4.18%, while the 3 year total shareholder return of 44.64% contrasts with a 1 year...

Redwire (RDW) Is Up 36.1% After Record Q2 Sales And Backlog - Has The Bull Case Changed?
Simply Wall St.23d agoneutral
Redwire (RDW) Is Up 36.1% After Record Q2 Sales And Backlog - Has The Bull Case Changed?

In the past week, Redwire Corporation reported second-quarter 2026 results showing sales rising to US$117.07 million from US$61.76 million a year earlier, with the net loss narrowing to US$40.97 million from US$96.98 million and full-year 2026 revenue guidance reaffirmed at US$450 million to US$500 million. Beyond the headline growth, Redwire emphasized a record contracted backlog and improving loss per share, suggesting its space and defense contract base is deepening even as the business...

Why Is Alphabet (GOOGL) Facing 3,000 Youth Lawsuits As Earnings Influence Grows?
Simply Wall St.23d agobearish
Why Is Alphabet (GOOGL) Facing 3,000 Youth Lawsuits As Earnings Influence Grows?

Alphabet (NasdaqGS:GOOGL) faces more than 3,000 youth addiction lawsuits in US federal court after a key ruling denied dismissal efforts by major social media companies. The court decision leaves Google and peers exposed to potential legal findings on platform design and user harm, with possible knock-on effects for future regulation. FactSet data shows Alphabet has had an outsized impact on S&P 500 earnings growth this quarter, highlighting its weight in overall index performance. The...

Ouster (OUST) Lands Utah BlueCity Expansion Across 160 More Intersections
Simply Wall St.23d agoneutral
Ouster (OUST) Lands Utah BlueCity Expansion Across 160 More Intersections

Ouster (NasdaqGS: OUST) secured a multimillion dollar contract expansion with the Utah Department of Transportation to deploy its BlueCity lidar traffic management solution. The agreement covers BlueCity deployments at 160 additional intersections across Utah for advanced traffic management. The rollout uses Ouster's next generation OS1 Max Rev8 lidar sensors, which include long range detection and native color capabilities. This contract is tied directly to Ouster's focus on intelligent...

Investing.com23d agobullish
CAVA Group surges on revenue beat, robust traffic growth

Investing.com -- CAVA Group Inc (NYSE:CAVA) reported second quarter results that exceeded revenue expectations, driving shares up as much as 13% in after-hours trading Tuesday as the Mediterranean fast-casual chain demonstrated continued momentum in same-restaurant sales and traffic growth.

5 Insightful Analyst Questions From onsemi’s Q2 Earnings Call
StockStory23d agoneutral
5 Insightful Analyst Questions From onsemi’s Q2 Earnings Call

onsemi’s second quarter performance was driven by surging demand in its AI data center segment and ongoing portfolio reshaping efforts. Management pointed to robust momentum in advanced power systems, particularly for AI workloads, and highlighted content expansion in automotive and energy infrastructure. CEO Hassane El-Khoury explained that, “AI data center remains our fastest-growing market,” noting wins with key hyperscalers and design-ins with leading global customers. The company also cited

Cava Stock Jumps on Foot Traffic Gains
Barrons.com23d agobullish
Cava Stock Jumps on Foot Traffic Gains

Cava Group stock jumped more than 10% in Tuesday’s after hours trading after the restaurant chain delivered stronger-than-expected second quarter results as customer foot traffic continued to rise. For the quarter ended July 12, Cava’s restaurant revenue increased 31.3% to $365.4 million, leaving total company revenue at $368.4 million. Wall Street analysts polled by FactSet had expected roughly $360 million in revenue.

What Is The Market Really Expecting From AVGO Stock?
Trefis23d agoneutral
What Is The Market Really Expecting From AVGO Stock?

At $422, Broadcom (AVGO) is being priced to deliver 26% revenue growth annually for the next 5 years simply to defend today's 68.4x multiple. That sits below the 32% the business is currently growing at, which is the unusual part. The multiple has already priced in a slowdown that has not yet appeared.

Spotify Just Legalized Fan Remixes, So What Does It Mean For SPOT?
Insider Monkey23d agoneutral
Spotify Just Legalized Fan Remixes, So What Does It Mean For SPOT?

On August 4, Spotify (NYSE:SPOT) and Merlin announced a licensing agreement that lets independent artists opt into Spotify’s upcoming fan-made covers and remixing tool. It sounds like a minor feature rollout, but the stock has been under pressure for most of the year, and this is one of several engagement bets management is leaning on […]